News
Leo Lens Pharma Excited to Have Its Lead Asset Ready for Human Clinical Evaluation
June 23, 2020 | posted by Leo Lens
Patented product for the novel treatment of glaucoma is IND-ready
Leo Lens Pharma Proud to Be Selected as a Connect 2020 Cool Company
May 29, 2020 | posted by Leo Lens
Leo Lens Pharma Appoints Dan Myers CEO
April 15, 2020 | posted by Leo Lens
Accomplished Ophthalmic Executive to Lead Company in Its Next Phase
Myopia Management Focus of Pipeline Expansion for Leo Lens Pharma
February 20, 2020 | posted by Leo Lens
Leo Lens Pharma Strengthens its Pipeline with New IP Protection for a Unique Atropine-based Myopia Management Solution February 19, 2020 08:51 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Today, Leo Lens Pharma (formerly DBA as Leo Lens Technology Co., Inc.) announced it received a notice of allowance from the USPTO for a patent for the use […]
Biocom Member Spotlight: Interview with Kokila & Praful Doshi, Co-Founders of Leo Lens Technology
September 5, 2019 | posted by Leo Lens
Leo Lens was featured in a Member Spotlight article from Biocom. Read it here: https://www.biocom.org/corporate-newsletter/newsletter-article/?article=Biocom-Member-Spotlight-Interview-with-Kokila-and-Praful-Doshi-Co-Founders-of-Leo-Lens-Technology
Leo Lens Selected as Presenting Company at Octane MTIF 2018
October 10, 2018 | posted by Leo Lens
Leo Lens was selected from over 150 companies to be a presenting company at Octane’s 2018 Medical Technology Innovation Forum. For more information on the event go to www.mtif2018.com.
Associations
© 2018 Leo Lens Technology, Inc.